Demographics |
|
Age, years (mean ± SD) |
60.09 ± 14.05 |
Female Sex, N (%) |
14 (42.42%) |
BMI (mean ± SD) |
29.97 ± 7.00 |
Comorbidities |
|
Hypertension, N (%) |
21 (63.64%) |
Hyperlipidemia, N (%) |
14 (42.42%) |
Diabetes, N (%) |
16 (48.48%) |
COPD/Asthma, N (%) |
5 (15.15%) |
Chronic Kidney Disease, N (%) |
10 (30.30%) |
Coronary Artery Disease, N (%) |
4 (12.12%) |
Congestive Heart Failure , N (%) |
7 (21.21%) |
Laboratory Values |
|
WBC Count (cells/uL) |
13.65 ± 11.22 |
Creatinine (mg/dL) |
3.27 ± 2.47 |
Ferritin (ng/mL) |
1992.24 ± 1807.34 |
C-Reactive Protein (mg/L) |
202.16 ± 101.37 |
ESR (mm/hr) |
84.30 ± 28.29 |
D-dimer (ug/mL) |
8.26 ± 6.67 |
Lactate Dehydrogenase (U/L) |
715.30 ± 869.22 |
High Sensitivity Troponin-T (ng/L) |
116.47 ± 158.19 |
Clinical Features |
|
Mechanical Ventilation, N (%) |
33 (100.00%) |
Renal Replacement Therapy, N (%) |
11 (33.33%) |
Vasopressor Requirement, N (%) |
24 (72.73%) |
Anti-arrhythmic use, N (%) |
3 (9.09%) |
Anticoagulation use, N (%) |
8 (24.24%) |
Hydroxychloroquine use, N (%) |
26 (78.79%) |
Azithromycin use, N (%) |
27 (81.82%) |